VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 2nd ASIA PACIFIC ECHOCARDIOGRAPHY COURSE Post Luc M.

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Jul 09, 2024 9:04am

57 Views

Post# 36124128

RE:2nd ASIA PACIFIC ECHOCARDIOGRAPHY COURSE Post Luc M.

Good to remember Ventripoint is thrilled to announce that Dr Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, has joined the Ventripoint Clinical Advisory Board. Dr Mertens has experience using the VMS+ system at Sick Kids and will be able to provide insight for the next upgrades of the VMS+.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Sept. 12, 2024